Disc Medicine (IRON) Depreciation & Amortization (CF) (2022 - 2026)
Disc Medicine (IRON) posted quarterly Depreciation & Amortization (CF) of $90000.0 for Q2 2026, up 5.88% year-over-year from $85000.0 in Q2 2025, and up 1.12% quarter-over-quarter from $89000.0 in Q1 2026.
Powered by 
Analysis
Disc Medicine (IRON) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $90000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 5.88% year-over-year to $90000.0; the TTM figure through Jun 2026 stood at $355000.0 (up 184.0% YoY), while the FY2025 annual figure was $281000.0, up 80.13% from the prior year.
- Depreciation & Amortization (CF) rose to $90000.0 in Q2 2026 per IRON's latest filing, from $89000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $110000.0 in Q2 2024 and bottomed at $9000.0 in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $44722.2 across 5 years, with a median of $25000.0 in 2022.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) plunged 72.31% — and 2025, when it jumped 888.89%.
- Disc Medicine's Depreciation & Amortization (CF) stood at $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then sank by 64.0% to $9000.0 in 2024, then surged by 888.89% to $89000.0 in 2025, then gained by 1.12% to $90000.0 in 2026.
- Business Quant data shows IRON's Depreciation & Amortization (CF) at $90000.0 in Q2 2026, $89000.0 in Q1 2026, and $89000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - | 90,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90,000.00 |
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 18,000.00 |